Electra Therapeutics Inc. (ETRA) vs Cartesian Therapeutics, Inc. (RNAC)
A side-by-side comparison of Electra Therapeutics Inc. and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETRA
Electra Therapeutics Inc.
$9.82HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RNAC
Cartesian Therapeutics, Inc.
$6.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ETRA vs RNAC
growth of $100 · dividends reinvested · last 1yETRA -26.5% (-26.5%/yr)RNAC -11.1% (-11.1%/yr)RNAC compounded faster over this window
ETRA RNAC
Metrics side by side
Total return (annualized)
| Metric | ETRA | RNAC |
|---|---|---|
| Total return (1Y) | N/A | -29.81% |
| Total return CAGR (3Y) | N/A | -39.02% |
| Total return CAGR (5Y) | N/A | -44.03% |
| Total return CAGR (10Y) | N/A | -33.65% |
ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.